Login to Your Account



Are We There Yet?

At AACR Meeting, Optimism That Progress Will Continue

By Anette Breindl


Wednesday, April 6, 2011
It might be called the cancer patient's theory of relativity: Even when drug development moves at record speed, that speed is still glacial from the perspective of the patient with cancer whose life expectancy may, in the worst cases, be measured in months.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription